![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Suzhou Lixin Pharmaceutical Co., Ltd. Suzhou Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Dacarbazine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-315 - Rev 02
This Chemical Type CEP, issued on February 17, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1691 associated with this CEP further emphasizes